Literature DB >> 12834633

Cerebral perfusion imaging using contrast-enhanced MRI.

P Keston1, A D Murray, A Jackson.   

Abstract

New developments in fast magnetic resonance imaging (MRI) have enabled imaging of cerebral haemodynamics. This article describes the theory behind perfusion imaging and provides an overview of the most commonly used MRI technique. Limitations of this technique are described, and the potential clinical applications are discussed, with particular attention to the role of perfusion imaging in the context of stroke and brain tumour.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12834633     DOI： 10.1016/s0009-9260(03)00130-2

Source DB:  PubMed          Journal:  Clin Radiol        ISSN： 0009-9260            Impact factor:   2.350


  16 in total

Review 1.  The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists.

Authors:  Mariane Le Fur; Peter Caravan
Journal:  Metallomics       Date:  2019-02-20       Impact factor: 4.526

2.  ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.

Authors:  K Welker; J Boxerman; A Kalnin; T Kaufmann; M Shiroishi; M Wintermark
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-23       Impact factor: 3.825

3.  Cortical calcification in Sturge-Weber Syndrome on MRI-SWI: relation to brain perfusion status and seizure severity.

Authors:  Jianlin Wu; Bisher Tarabishy; Jiani Hu; Yanwei Miao; Zhaocheng Cai; Yang Xuan; Michael Behen; Meng Li; Yongquan Ye; Richard Shoskey; E Mark Haacke; Csaba Juhász
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

Review 4.  Whole animal imaging.

Authors:  Gurpreet Singh Sandhu; Luis Solorio; Ann-Marie Broome; Nicolas Salem; Jeff Kolthammer; Tejas Shah; Chris Flask; Jeffrey L Duerk
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Jul-Aug

5.  A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism.

Authors:  Eric M Gale; Hsiao-Ying Wey; Ian Ramsay; Yi-Fen Yen; David E Sosnovik; Peter Caravan
Journal:  Radiology       Date:  2017-11-08       Impact factor: 11.105

6.  Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging.

Authors:  Jeffry R Alger; Timothy J Schaewe; Tom C Lai; Andrew J Frew; Paul M Vespa; Maria Etchepare; David S Liebeskind; Jeffrey L Saver; S Chelsea Kidwell
Journal:  J Magn Reson Imaging       Date:  2009-01       Impact factor: 4.813

7.  Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas.

Authors:  A Di Costanzo; S Pollice; F Trojsi; G M Giannatempo; T Popolizio; L Canalis; M Armillotta; A Maggialetti; A Carriero; G Tedeschi; T Scarabino
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

8.  Characterization of gadolinium-based dynamic susceptibility contrast perfusion measurements in permanent and transient MCAO models with volumetric based validation by CASL.

Authors:  Bernt T Bråtane; Ronn P Walvick; Claire Corot; Eric Lancelot; Marc Fisher
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-14       Impact factor: 6.200

9.  Manganese-Based Contrast Agents for Magnetic Resonance Imaging of Liver Tumors: Structure-Activity Relationships and Lead Candidate Evaluation.

Authors:  Junfeng Wang; Huan Wang; Ian A Ramsay; Derek J Erstad; Bryan C Fuchs; Kenneth K Tanabe; Peter Caravan; Eric M Gale
Journal:  J Med Chem       Date:  2018-09-25       Impact factor: 7.446

10.  A Manganese Alternative to Gadolinium for MRI Contrast.

Authors:  Eric M Gale; Iliyana P Atanasova; Francesco Blasi; Ilknur Ay; Peter Caravan
Journal:  J Am Chem Soc       Date:  2015-12-04       Impact factor: 15.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.